DCRA
Pharmaceutical preparations for the treatment of elevated circulating cholesterol, vascular inflammation, atherosclerosis, cardiovascular disease, diabetes mellitus, infection and/or inflammation in immunosuppressed subjects, cancer, organ transplant rejection and graft-versus-host-disease, bacteremia, sepsis, septic shock, Acute Respiratory Distress Syndrome, pain, wounds, respiratory disorders, neurofibromatosis, rheumatoid arthritis, Waginer's granulomatosis, Kawasaki's disease, lupus erat...
Abandoned · July 29, 2008 · 77534269 ·